Momentus Inc. 8-K Summary: Special Meeting Results
Business Context and Reporting Period
Momentus Inc. (MNTS) filed this Form 8-K on February 6, 2026, to report the results of its 2026 Special Meeting of Stockholders held on the same date. The meeting addressed seven proposals primarily related to Nasdaq listing rule compliance for the issuance of Class A common stock upon the exercise of various convertible notes, warrants, and an Equity Line of Credit (ELOC), as well as a proposal to increase authorized share capital.
Key Financial Metrics
This filing is a current report regarding corporate governance and voting outcomes. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The filing notes that voting numbers are based on outstanding shares as of December 10, 2025, and have not been adjusted for a reverse stock split effected on December 17, 2025.
Material Changes and Voting Outcomes
Stockholders approved six of the seven proposals submitted. The only proposal rejected was the Share Increase Proposal.
- Approved Proposals:
- Proposal 1 (Convertible Notes and Warrants): Approved (8,382,509 For vs. 317,830 Against).
- Proposal 2 (Equity Line of Credit): Approved (8,382,119 For vs. 322,679 Against).
- Proposal 3 (October 2025 Inducement Warrants): Approved (8,385,074 For vs. 320,037 Against).
- Proposal 5 (December 2025 Inducement Warrants): Approved (8,374,593 For vs. 324,939 Against).
- Proposal 6 (Adjournment): Approved (14,593,925 For vs. 792,678 Against).
- Proposal 7 (January 2026 Warrants): Approved (8,188,310 For vs. 167,913 Against).
- Rejected Proposal:
- Proposal 4 (Share Increase): Not Approved. The proposal to increase authorized Class A common stock from 250,000,000 to 260,000,000 shares received 14,445,976 votes For and 941,345 votes Against. Note: The text states the proposal was not approved despite the "For" votes significantly exceeding "Against" votes; this summary reflects the explicit textual conclusion of the filing.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the context of the voting proposals. The approval of the warrant and ELOC proposals enables the company to issue shares upon exercise of these instruments in compliance with Nasdaq rules. The rejection of the share increase proposal limits the company's ability to issue additional authorized shares beyond the current 250,000,000 limit without further shareholder action.
Investor Verification Checklist
- Verify the final status of the Share Increase Proposal (Proposal 4) given the discrepancy between the vote count (majority For) and the filing's statement that it was "not approved."
- Confirm the impact of the December 17, 2025 reverse stock split on the current authorized share count and outstanding share calculations.
- Review the definitive proxy statement filed on December 29, 2025, for detailed terms of the Convertible Notes, Warrants, and ELOC.
- Monitor subsequent filings for any attempts to re-submit the Share Increase Proposal or alternative capital raising strategies.